Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 29, 2018 |
Dec. 30, 2017 |
Dec. 31, 2016 |
|
| Accounting Policies [Abstract] | |||
| Maturity period (less than) | 90 days | ||
| Foreign bank balance | $ 6,943,000 | $ 6,035,000 | |
| Allowance for doubtful accounts | (846,000) | (1,121,000) | |
| Proceeds from sale of trade receivables | 215,833,000 | 214,527,000 | |
| Loss from sale of trade receivables | 2,233,000 | 1,426,000 | |
| Risk cover by third party, minimum (up to) | 250,000 | ||
| Loss limit covered under self-insurance | 250,000 | ||
| Research and development costs | $ 2,181,000 | $ 2,216,000 | $ 2,277,000 |
| Dividend yield (as a percent) | 0.00% | ||
| X | ||||||||||
- Definition Cash And Cash Equivalents Held In Foreign Bank Accounts No definition available.
|
| X | ||||||||||
- Definition Maximum Period For Classifying As Cash And Cash Equivalents No definition available.
|
| X | ||||||||||
- Definition Minimum Amount Of Risk Covered From Third Party Insurers No definition available.
|
| X | ||||||||||
- Definition Self Insurance Stop Loss Limit Per Participant No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition For an unclassified balance sheet, a valuation allowance for receivables due a company that are expected to be uncollectible. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Reflects the net positive or negative amount derived from subtracting from net proceeds of sale, the carrying amounts, net of allocated reserves, of accounts receivable transferred to a third party in a transaction that qualifies for sales treatment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow associated with the proceeds from sale and collection of receivables during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|